Idexx Laboratories Stock Current Ratio

IDXX Stock

USD 499.30 10.06 2.06%

IDEXX Laboratories fundamentals help investors to digest information that contributes to IDEXX Laboratories' financial success or failures. It also enables traders to predict the movement of IDEXX Stock. The fundamental analysis module provides a way to measure IDEXX Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IDEXX Laboratories stock.

		Last Reported	Projected for Next Year
	Current Ratio	1.57	2.84

Current Ratio is likely to rise to 2.84 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

IDEXX Laboratories Company Current Ratio Analysis

IDEXX Laboratories' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Current Ratio

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current IDEXX Laboratories Current Ratio

0.89 X

Most of IDEXX Laboratories' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IDEXX Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

IDEXX Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for IDEXX Laboratories is extremely important. It helps to project a fair market value of IDEXX Stock properly, considering its historical fundamentals such as Current Ratio. Since IDEXX Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IDEXX Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IDEXX Laboratories' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.73	0.33	0.91	0.95	0.99	0.82	0.96	0.72	0.11	0.54	-0.89	0.98	0.6	0.8	0.62	0.05	0.72	0.85	-0.53	-0.46	0.79	0.71	0.7	0.69
Total Stockholder Equity	0.73		-0.39	0.89	0.59	0.71	0.2	0.69	0.61	-0.39	0.14	-0.56	0.68	0.09	0.5	0.0	0.52	0.14	0.47	-0.72	-0.44	0.77	0.79	0.8	0.73
Net Debt	0.33	-0.39		0.0	0.47	0.35	0.79	0.31	0.2	0.74	0.51	-0.41	0.37	0.64	0.46	0.81	-0.61	0.75	0.53	0.24	0.09	0.07	-0.1	-0.24	-0.14
Retained Earnings	0.91	0.89	0.0		0.84	0.9	0.55	0.83	0.76	-0.11	0.33	-0.84	0.88	0.42	0.74	0.33	0.33	0.45	0.73	-0.72	-0.44	0.87	0.76	0.71	0.74
Accounts Payable	0.95	0.59	0.47	0.84		0.97	0.86	0.87	0.74	0.15	0.53	-0.91	0.96	0.69	0.86	0.71	0.06	0.79	0.89	-0.55	-0.47	0.7	0.61	0.56	0.6
Net Receivables	0.99	0.71	0.35	0.9	0.97		0.82	0.92	0.7	0.06	0.51	-0.89	0.99	0.64	0.82	0.66	0.08	0.75	0.88	-0.6	-0.51	0.78	0.69	0.68	0.68
Total Liab	0.82	0.2	0.79	0.55	0.86	0.82		0.8	0.51	0.49	0.65	-0.8	0.84	0.78	0.72	0.89	-0.37	0.92	0.82	-0.16	-0.29	0.48	0.35	0.33	0.38
Total Current Assets	0.96	0.69	0.31	0.83	0.87	0.92	0.8		0.64	0.22	0.56	-0.78	0.91	0.48	0.69	0.57	-0.08	0.67	0.76	-0.34	-0.34	0.75	0.7	0.72	0.68
Intangible Assets	0.72	0.61	0.2	0.76	0.74	0.7	0.51	0.64		0.15	0.63	-0.8	0.67	0.39	0.84	0.32	0.34	0.37	0.61	-0.41	-0.24	0.57	0.51	0.3	0.35
Short Term Debt	0.11	-0.39	0.74	-0.11	0.15	0.06	0.49	0.22	0.15		0.47	-0.12	0.07	0.16	0.17	0.3	-0.76	0.27	0.15	0.59	0.63	0.08	-0.22	-0.44	-0.2
Common Stock	0.54	0.14	0.51	0.33	0.53	0.51	0.65	0.56	0.63	0.47		-0.64	0.52	0.61	0.66	0.56	-0.24	0.55	0.52	0.1	-0.19	0.1	0.16	0.08	-0.03
Treasury Stock	-0.89	-0.56	-0.41	-0.84	-0.91	-0.89	-0.8	-0.78	-0.8	-0.12	-0.64		-0.9	-0.79	-0.9	-0.69	-0.15	-0.73	-0.86	0.54	0.52	-0.59	-0.53	-0.47	-0.45
Property Plant Equipment	0.98	0.68	0.37	0.88	0.96	0.99	0.84	0.91	0.67	0.07	0.52	-0.9		0.69	0.81	0.68	0.03	0.77	0.89	-0.58	-0.53	0.76	0.66	0.66	0.67
Current Deferred Revenue	0.6	0.09	0.64	0.42	0.69	0.64	0.78	0.48	0.39	0.16	0.61	-0.79	0.69		0.74	0.89	-0.15	0.88	0.82	-0.32	-0.59	0.2	0.28	0.24	0.04
Good Will	0.8	0.5	0.46	0.74	0.86	0.82	0.72	0.69	0.84	0.17	0.66	-0.9	0.81	0.74		0.67	0.2	0.72	0.91	-0.51	-0.41	0.56	0.62	0.36	0.21
Long Term Debt	0.62	0.0	0.81	0.33	0.71	0.66	0.89	0.57	0.32	0.3	0.56	-0.69	0.68	0.89	0.67		-0.28	0.98	0.81	-0.16	-0.49	0.2	0.29	0.28	0.09
Net Tangible Assets	0.05	0.52	-0.61	0.33	0.06	0.08	-0.37	-0.08	0.34	-0.76	-0.24	-0.15	0.03	-0.15	0.2	-0.28		-0.26	0.01	-0.66	-0.43	0.11	0.33	0.32	0.16
Long Term Debt Total	0.72	0.14	0.75	0.45	0.79	0.75	0.92	0.67	0.37	0.27	0.55	-0.73	0.77	0.88	0.72	0.98	-0.26		0.88	-0.23	-0.52	0.33	0.43	0.4	0.2
Capital Surpluse	0.85	0.47	0.53	0.73	0.89	0.88	0.82	0.76	0.61	0.15	0.52	-0.86	0.89	0.82	0.91	0.81	0.01	0.88		-0.53	-0.5	0.62	0.69	0.51	0.3
Deferred Long Term Liab	-0.53	-0.72	0.24	-0.72	-0.55	-0.6	-0.16	-0.34	-0.41	0.59	0.1	0.54	-0.58	-0.32	-0.51	-0.16	-0.66	-0.23	-0.53		0.6	-0.6	-0.55	-0.56	-0.51
Short Long Term Debt	-0.46	-0.44	0.09	-0.44	-0.47	-0.51	-0.29	-0.34	-0.24	0.63	-0.19	0.52	-0.53	-0.59	-0.41	-0.49	-0.43	-0.52	-0.5	0.6		-0.08	-0.46	-0.68	-0.3
Long Term Investments	0.79	0.77	0.07	0.87	0.7	0.78	0.48	0.75	0.57	0.08	0.1	-0.59	0.76	0.2	0.56	0.2	0.11	0.33	0.62	-0.6	-0.08		0.67	0.55	0.73
Net Invested Capital	0.71	0.79	-0.1	0.76	0.61	0.69	0.35	0.7	0.51	-0.22	0.16	-0.53	0.66	0.28	0.62	0.29	0.33	0.43	0.69	-0.55	-0.46	0.67		0.82	0.42
Net Working Capital	0.7	0.8	-0.24	0.71	0.56	0.68	0.33	0.72	0.3	-0.44	0.08	-0.47	0.66	0.24	0.36	0.28	0.32	0.4	0.51	-0.56	-0.68	0.55	0.82		0.69
Capital Stock	0.69	0.73	-0.14	0.74	0.6	0.68	0.38	0.68	0.35	-0.2	-0.03	-0.45	0.67	0.04	0.21	0.09	0.16	0.2	0.3	-0.51	-0.3	0.73	0.42	0.69

Click cells to compare fundamentals

IDEXX Current Ratio Historical Pattern

Today, most investors in IDEXX Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various IDEXX Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of IDEXX Laboratories current ratio as a starting point in their analysis.

IDEXX Laboratories Current Ratio

Timeline

Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

Competition

Predict IDEXX Laboratories

Current Ratio Over Time

IDEXX Price To Sales Ratio

Price To Sales Ratio

13.22

At this time, IDEXX Laboratories' Price To Sales Ratio is fairly stable compared to the past year.

In accordance with the recently published financial statements, IDEXX Laboratories has a Current Ratio of 0.89 times. This is 69.42% lower than that of the Health Care Equipment & Supplies sector and 80.04% lower than that of the Health Care industry. The current ratio for all United States stocks is 58.8% higher than that of the company.

IDEXX Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IDEXX Laboratories' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics of similar companies.

IDEXX Laboratories is currently under evaluation in current ratio category among related companies.

IDEXX Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.

Environment Score

Governance Score

Social Score

IDEXX Fundamentals

	Return On Equity	0.81
	Return On Asset	0.23
	Profit Margin	0.23 %
	Operating Margin	0.27 %
	Current Valuation	41.68 B
	Shares Outstanding	83.05 M
	Shares Owned By Insiders	0.92 %
	Shares Owned By Institutions	92.19 %
	Number Of Shares Shorted	1.71 M
	Price To Earning	61.31 X
	Price To Book	27.85 X
	Price To Sales	11.29 X
	Revenue	3.66 B
	Gross Profit	2 B
	EBITDA	1.1 B
	Net Income	845.04 M
	Cash And Equivalents	114.36 M
	Cash Per Share	1.37 X
	Total Debt	947.88 M
	Debt To Equity	3.27 %
	Current Ratio	0.89 X
	Book Value Per Share	17.88 X
	Cash Flow From Operations	906.51 M
	Short Ratio	4.54 X
	Earnings Per Share	10.08 X
	Price To Earnings To Growth	4.75 X
	Target Price	604.62
	Number Of Employees	11 K
	Beta	1.26
	Market Capitalization	41.05 B
	Total Asset	3.26 B
	Retained Earnings	4.44 B
	Working Capital	543.71 M
	Current Asset	821.63 M
	Current Liabilities	856.76 M
	Net Asset	3.26 B

About IDEXX Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IDEXX Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:

How To Invest In IDEXX

Details

Is IDEXX Stock a good investment?

Details

What is IDEXX Laboratories' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out IDEXX Laboratories Piotroski F Score and IDEXX Laboratories Altman Z Score analysis.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Bonds Directory Find actively traded corporate debentures issued by US companies
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years

Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.121

Earnings Share

10.08

Revenue Per Share

44.073

Quarterly Revenue Growth

0.088

Return On Assets

0.2283

The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Idexx Laboratories Stock Current Ratio

IDEXX Laboratories Company Current Ratio Analysis

Current Ratio

Current Asset

Current Liabilities

Current IDEXX Laboratories Current Ratio

IDEXX Current Ratio Driver Correlations

IDEXX Current Ratio Historical Pattern

IDEXX Price To Sales Ratio

Price To Sales Ratio

13.22

IDEXX Current Ratio Peer Comparison

IDEXX Laboratories ESG Sustainability

IDEXX Fundamentals

About IDEXX Laboratories Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for IDEXX Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY